学术探索
学术期刊
文章热点
数据分析
智能智评

Importance of surrogate markers in evaluation of antiviral therapy for HIV infection

被引：13
作者：
Deyton, L
机构：
[1] Division of AIDS, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD
来源：
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION | 1996年 / 276卷 / 02期
关键词：
D O I：
10.1001/jama.276.2.159
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
[No abstract available]
引用
收藏
页码：159 / 160
页数：2
相关论文
共 28 条
  • [1] CD4+ LYMPHOCYTES ARE AN INCOMPLETE SURROGATE MARKER FOR CLINICAL PROGRESSION IN PERSONS WITH ASYMPTOMATIC HIV-INFECTION TAKING ZIDOVUDINE
    CHOI, SS
    LAGAKOS, SW
    SCHOOLEY, RT
    VOLBERDING, PA
    [J]. ANNALS OF INTERNAL MEDICINE, 1993, 118 (09) : 674 - 680
  • [2] Treatment of human immunodeficiency virus infection with saquinavir, zidovudine, and zalcitabine
    Collier, AC
    Coombs, RW
    Schoenfeld, DA
    Bassett, RL
    Timpone, J
    Baruch, A
    Jones, M
    Facey, K
    Whitacre, C
    McAuliffe, VJ
    Friedman, HM
    Merigan, TC
    Reichman, RC
    Hooper, C
    Corey, L
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 1996, 334 (16) : 1011 - 1017
  • [3] PLASMA VIREMIA IN HUMAN IMMUNODEFICIENCY VIRUS-INFECTION
    COOMBS, RW
    COLLIER, AC
    ALLAIN, JP
    NIKORA, B
    LEUTHER, M
    GJERSET, GF
    COREY, L
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 1989, 321 (24) : 1626 - 1631
  • [4] DAQUILA RT, 1995, P 2 NAT C HUM RETR R
  • [5] SERUM P24 ANTIGEN LEVEL AS AN INTERMEDIATE END-POINT IN CLINICAL-TRIALS OF ZIDOVUDINE IN PEOPLE INFECTED WITH HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1
    DEGRUTTOLA, V
    BECKETT, LA
    COOMBS, RW
    ARDUINO, JM
    BALFOUR, HH
    RASHEED, S
    HOLLINGER, FB
    FISCHL, MA
    VOLBERDING, P
    GROUP, TACT
    [J]. JOURNAL OF INFECTIOUS DISEASES, 1994, 169 (04) : 713 - 721
  • [6] RISK OF AIDS RELATED COMPLEX AND AIDS IN HOMOSEXUAL MEN WITH PERSISTENT HIV ANTIGENEMIA
    DEWOLF, F
    GOUDSMIT, J
    PAUL, DA
    LANGE, JMA
    HOOIJKAAS, C
    SCHELLEKENS, P
    COUTINHO, RA
    VANDERNOORDAA, J
    [J]. BMJ-BRITISH MEDICAL JOURNAL, 1987, 295 (6598): : 569 - 572
  • [7] TREATMENT WITH LAMIVUDINE, ZIDOVUDINE, OR BOTH IN HIV-POSITIVE PATIENTS WITH 200 TO 500 CD4+ CELLS PER CUBIC MILLIMETER
    ERON, JJ
    BENOIT, SL
    JEMSEK, J
    MACARTHUR, RD
    SANTANA, J
    QUINN, JB
    KURITZKES, DR
    FALLON, MA
    RUBIN, M
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 1995, 333 (25) : 1662 - 1669
  • [8] PREDICTIVE MARKERS FOR THE ACQUIRED IMMUNODEFICIENCY SYNDROME (AIDS) IN HEMOPHILIACS - PERSISTENCE OF P24 ANTIGEN AND LOW T4 CELL COUNT
    EYSTER, ME
    BALLARD, JO
    GAIL, MH
    DRUMMOND, JE
    GOEDERT, JJ
    [J]. ANNALS OF INTERNAL MEDICINE, 1989, 110 (12) : 963 - 969
  • [9] THE HUMAN IMMUNODEFICIENCY VIRUS - INFECTIVITY AND MECHANISMS OF PATHOGENESIS
    FAUCI, AS
    [J]. SCIENCE, 1988, 239 (4840) : 617 - 622
  • [10] SURROGATE AND AUXILIARY END-POINTS IN CLINICAL-TRIALS, WITH POTENTIAL APPLICATIONS IN CANCER AND AIDS RESEARCH
    FLEMING, TR
    PRENTICE, RL
    PEPE, MS
    GLIDDEN, D
    [J]. STATISTICS IN MEDICINE, 1994, 13 (09) : 955 - 968
123